GENNEX (GENNEX) Fair Value & Analysis

IN · Market cap ₹2.5B

G GENNEX GENNEX · BSE

Price₹10.16

Fair Value₹14.68

Upside+44.5%

Quality29/100

Watch GENNEX for free — get notified when fair value or trend changes. Watch for free

Evidence: Medium Range ₹11.01 – ₹18.35

Fair value as of: Jul 5, 2026

From 14 valuation models · updated 3 days ago

Share price −8.3% over the past month.

Price vs Fair Value (12 months)

12‑month range ₹7.13 – ₹17.02 · fair‑value band ₹11.01 – ₹18.35 · the ₹10.16 price screens below the ₹14.68 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

GENNEX (GENNEX) currently trades at ₹10.16, while our model-based Fair Value estimate is ₹14.68 — implying the stock looks roughly 44.5% undervalued today. We read business quality at 29/100 (below-average quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, GENNEX generated revenue of ₹1.7B at a net margin of 12.2%. Revenue grew 51.2% year over year. It earns a return on equity of 9.8%. Net debt stands at ₹793M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹11.01 (bear case) to ₹18.35 (bull case); at ₹10.16, the current price sits below that range. The share trades about 41% below its 52-week high and 44% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹1.7B

Revenue growth (YoY) +51.2%

Net margin 12.2%

Return on equity 9.8%

Free cash flow −₹756M FY2025

P/E ratio 13.4

More key figures

Operating margin 7.3%

EPS (TTM) ₹0.7600

EPS growth (YoY) -36.4%

Net debt ₹793M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

GENNEX reported revenue of ₹1.7B in FY2025 versus ₹612M in FY2021, a compound +29.6%/yr. Reported net income was ₹210M in FY2025, compounding +52.1%/yr from FY2021.

Revenue +29.6%/yr

FY21 ₹612M

FY22 ₹656M

FY23 ₹867M

FY24 ₹1.4B

FY25 ₹1.7B

Net income +52.1%/yr

FY21 ₹39.2M

FY22 ₹49.2M

FY23 ₹132M

FY24 ₹181M

FY25 ₹210M

Is GENNEX fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

📤 Share or link this analysis

𝕏 Post WhatsApp LinkedIn Reddit

🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

GENNEX · Fair Value
₹14.68 +44%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/GENNEX" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">GENNEX · Fair Value</span><br><b style="font-size:20px">₹14.68</b> <span style="color:#7BB290;font-weight:700;font-size:14px">+44%</span></span><span style="font-size:11px;color:#7BB290;font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "GENNEX Fair Value". https://www.fairvalue-calculator.com/stock/GENNEX

Explore undervalued stocks

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is GENNEX (GENNEX) undervalued?

As of Jul 5, 2026, our model estimates a fair value of ₹14.68 versus a price of ₹10.16 — about +44% (undervalued). Model-based estimate, not financial advice.

What is the fair value of GENNEX?

Our model-based fair value for GENNEX is ₹14.68 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹10.16.

What is the quality score of GENNEX?

GENNEX has a Quality Score of 29/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of GENNEX (GENNEX)?

GENNEX reported trailing-twelve-month revenue of about ₹1.7B (latest available figure, as of Jul 5, 2026).

What is the net profit margin of GENNEX?

The net profit margin of GENNEX is about 12.2%, meaning it keeps roughly 12.2% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.